LLM-to-Flow Distillation enables natural-language control for drug design
Summary
Researchers have introduced a novel method called LLM-to-Flow Distillation (LFD), which enables scientific generators to align with high-level natural-language discovery goals without relying on task-specific proxy rewards. This innovation allows any lab to utilize large language models (LLMs) to create manageable sub-goals, significantly lowering the barriers for smaller teams in the realm of generative drug design. Notably, this method has shown superior performance, outperforming conventional scoring functions in therapeutic peptide and small-molecule design tasks. The breakthrough facilitates a more inclusive environment in drug discovery, enabling teams that could not previously access such technology to engage in advanced generative methods.